Related to CDC and Walter Reed to Leverage Biomatters’ Next-Gen Sequencing Data Analysis Software

• Exome Sequencing Finds Sweet Spot Between Whole-Genome and Targeted Sequencing
  Technique provides a cost-effective tool for dissecting diseases that have been intractable to conventional gene discovery.
  
• R&D Direction in 2012 for Sequencing Technologies Is Aimed at Clinical Medicine
  Companies are focused on making these platforms smaller and easier to use.
  
• Standardization Key to Taking Next-Generation Sequencing to the Next Level
  As NGS technology makes steady progress with faster and cheaper machines, regulation will have to keep up.
  
• Sequencing Firms Set Up Centers to Advance Genomics Research and Instrument Sales
  Strategy provides a feedback loop to improve instrumentation and develop new applications.
  
• Academic Sequencing Centers May Feel the Pinch of Budgetary Constraints and Data Deluge
  NHGRI renewed $416 million over four years in funding for three centers but warned of lower funds in the future.
  
• Presidential Panel Wrestles with Ethical Issues Linked to Clinical Use of Whole Genome Sequencing
  Final recommendations, to be presented this fall, will encompass technology delivery and informed consent.
  
• Sequencing in the Dark
  Analysis of Life Technologies’ Ion Torrent sequencing platform points to significance of photon-free technology.
  
• Will Roche Really Drop Illumina and Seek out Another Sequencing Firm?
  Oxford Nanopore and PacBio both have exciting technologies, but Illumina remains market leader.
  
• U.K. Groups Grapple with Ethical Issues Linked to Clinical Sequencing
  Questions cover data dissemination, bioinformatics, and more education.
  
• Illumina, Complete Genomics Prepare for Legal Battle over Sequencing IP
  Illumina filed the case stating that the Complete Genomics Analysis Platform infringes on three of its patents.
  
• President Barack Obama’s Administration Launches Big Data Initiative with $200M
  Aim is to augment techniques for data storage, access, and interpretation.
  
• Researchers Try to Answer the Question: Is Big Data Too Big?
  Better data-handling solutions key to leveraging the omics revolution.
  
• Leveraging the Cancer Transcriptome for New Drug Targets
  New analytical tools are advancing research efforts.
  
• App Connects Rare Disease Researchers to Data
  New mobile app aggregates chemistry data and other open science data to help advance research for a myriad of diseases.
  
• Are You Already Obsolete?
  To stay ahead in the ever-quickening world of research, scientists must be fast and cunning.
  
• Meningitis Outbreak Prompts Policy Review
  Compounding pharmacies anticipate new rules following the meningitis outbreak, including an answer to the longstanding question of federal vs. state oversight.
  
• NIH Update: Too Much Is Not Enough
  A surfeit of data and postdocs drive NIH’s new programs, but funding is uncertain.
  
• 10 Predictions That Will Transform Healthcare
  Peer into GEN's crystal ball for a glimpse of what's to come.
  
• Cancer Model Database Emerges from WOMB
  Oncology researchers wishing for a tool to help them find available models and services may have had their prayers answered.
  
• Moving Genomics Closer to the Clinic
  Foundation Medicine and Memorial Sloan-Kettering Cancer Center are working to translate genomic information into personalized cancer treatment.